← Product Code [NHH](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/NHH) · K013094 # ORTHOSONIX ENERGEX (K013094) _Orthosonix, Inc. · NHH · Dec 14, 2001 · Physical Medicine · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/NHH/K013094 ## Device Facts - **Applicant:** Orthosonix, Inc. - **Product Code:** [NHH](/submissions/PM/subpart-f%E2%80%94physical-medicine-therapeutic-devices/NHH.md) - **Decision Date:** Dec 14, 2001 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 890.5500 - **Device Class:** Class 2 - **Review Panel:** Physical Medicine - **Attributes:** Therapeutic ## Indications for Use The Energex is indicated for use for the temporary relief of chronic temporomandibular joint (TMJ) pain. ## Device Story Energex is a therapeutic medical device delivering pulsed radio-frequency energy to tissue. Used for temporary relief of chronic TMJ pain. Operates by applying electromagnetic energy to the affected joint area. Intended for clinical use by healthcare professionals. Output consists of pulsed radio-frequency energy; intended to provide symptomatic relief of pain. Benefits patient by reducing chronic TMJ discomfort. ## Clinical Evidence Evidence includes bench, animal, and clinical data. Specific metrics, sample sizes, and study designs not provided in the summary document. ## Technological Characteristics Shortwave diathermy device; delivers pulsed radio-frequency energy. Form factor is a therapeutic medical device. ## Regulatory Identification An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating. ## Special Controls *Classification.* Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9. ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH AND HUMAN SERVICES, USA" around the perimeter. Inside the circle is a stylized symbol of three human profiles facing right, with flowing lines representing connection and support. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 SEP 3 0 2005 Orthosonix, Incorporated C/O Mr. Russell Pagano 615 7th St NE, 1st Floor Washington, DC 20002 Re: K013094 Trade/Device Name: Orthosonix Energex ® Regulation Number: N/A Regulation Name: N/A Regulatory Class: Unclassified Product Code: NHH Dated: September 14, 2001 Received: September 17, 2001 Dear Mr. Pagano: This letter corrects our substantially equivalent letter of December 14, 2001. We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent, for the indications for use stated in the enclosure, to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {1}------------------------------------------------ Page 2 - Mr. Russell Pagano Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to continue marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your de-ice and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address http://www.fda.gov/cdrh/industry/support/index.html Sincerely yours, Qve Shih-Shin Liang, Ph.D. Chiu S. Lin, PhD Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ 510(k) Premarket Notification Orthosonix Energex 013094 Indication for Use Statement 510(k) Number (if known): Device Name: Orthosonix Energex® Indication for Use: The Energex is indicated for use for the temporary relief of chronic temporomandibular joint (TMJ) pain. Susan Runny 'Division Sign-Off) - Chision of Dign-Off) Division of Dental, Infection Control, ind General Hospital (k) Number _ KC ત્વા ii.CONFIDENTIAL Appendices {3}------------------------------------------------ # 510(k) Summary DEC 1 4 2001 Orthosonix, Inc. Energex® K013094 Sponsor 1. Orthosonix 180 Old Tappan Road Old Tappan, New Jersey 07675 Contact Person: Thomas Fagan President ## 2. Device Name | Classification Name: | Shortwave diathermy device | |----------------------|----------------------------| | Proprietary Name: | Orthosonix Energex® | ## 3. Indications for Use The Energex is indicated for use for the temporary relief of chronic temporomandibular joint (TMJ) pain. ## 4. Device Description The Energex is a therapeutic medical device that delivers pulsed radio-frequency energy to tissue as indicated for the relief of chronic TMJ pain. #### Basis for Substantial Equivalence રું. The Energex is substantially equivalent to shortwave diathermy devices that are also indicated for the relief of joint pain. This equivalence was shown through bench, animal and clinical data submitted in the 510(k). --- **Source:** [https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/NHH/K013094](https://fda.innolitics.com/submissions/NE/subpart-f%E2%80%94physical-medicine-therapeutic-devices/NHH/K013094) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com